Cargando…
Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches
The aldose reductase (AR) enzyme is an important target enzyme in the development of therapeutics against hyperglycaemia induced health complications such as retinopathy, etc. In the present study, a quantitative structure activity relationship (QSAR) evaluation of a dataset of 226 reported AR inhib...
Autores principales: | Bakal, Ravindra L., Jawarkar, Rahul D., Manwar, J.V., Jaiswal, Minal S., Ghosh, Arabinda, Gandhi, Ajaykumar, Zaki, Magdi E.A., Al-Hussain, Sami, Samad, Abdul, Masand, Vijay H., Mukerjee, Nobendu, Nasir Abbas Bukhari, Syed, Sharma, Praveen, Lewaa, Israa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257878/ https://www.ncbi.nlm.nih.gov/pubmed/35812153 http://dx.doi.org/10.1016/j.jsps.2022.04.003 |
Ejemplares similares
-
QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL(pro) Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics simulation and MMGBSA calculation approaches
por: Jawarkar, R.D., et al.
Publicado: (2022) -
QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads
por: Jawarkar, Rahul D., et al.
Publicado: (2022) -
QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA
por: Jawarkar, Rahul D., et al.
Publicado: (2022) -
QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human N-Myristoyltransferase (Hs-NMT) Inhibitors
por: Zaki, Magdi E. A., et al.
Publicado: (2021) -
Exploring potent aldose reductase inhibitors for anti-diabetic (anti-hyperglycemic) therapy: integrating structure-based drug design, and MMGBSA approaches
por: Shahab, Muhammad, et al.
Publicado: (2023)